PSNL (Personalis) Dividends Received


PSNL Personalis Inc PSNL
59 GF Score
Price $14.06
GF Value $2.08
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Personalis Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

PSNL
59GF Score
Personalis Inc PSNL
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Personalis (PSNL) Overvalued in 2026?

Based on GuruFocus' analysis, Personalis stock appears to be overvalued. The current stock price of $14.06 is trading 576% above its estimated GF Value™ of $2.08. GuruFocus considers Personalis to be Significantly Overvalued.

Key valuation signals for PSNL:

  • Dividends Received:
  • GF Value™: $2.08 vs. price of $14.06 (576% above fair value)
  • GF Score™: 59/100 with 9 warning signs

No single metric tells the full story. See the PSNL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Personalis Business Description

Other Exchanges 04X:Germany
Address 6600 Dumbarton Circle, Fremont, CA, USA, 94555
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
59GF Score

Get the complete analysis for PSNL

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$14.06
Price
$2.08
GF Value